Revance Therapeutics: Frowning At The FDA
Nastasic/E+ via Getty Images
Introduction and Review
The reason why I started contributing to Seeking Alpha was because of my confidence in the superiority of Revance Therapeutic’s (NASDAQ:RVNC) DAXI when compared to currently available botulinum toxin…
